Analyst Price Targets — LFCR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 16, 2026 11:32 am | — | Barrington | $6.50 | $5.49 | TheFly | Lifecore price target raised to $6.50 from $6 at Barrington |
| April 29, 2026 11:33 am | — | Barrington | $6.00 | $5.12 | TheFly | Lifecore price target raised to $6 from $5.50 at Barrington |
| October 4, 2024 1:16 pm | Jacob Johnson | Stephens | $5.00 | $5.38 | StreetInsider | Stephens Reiterates Equal Weight Rating on Lifecore Biomedical (LFCR) |
| September 5, 2024 8:59 am | Matthew Hewitt | Craig-Hallum | $8.00 | $4.22 | TheFly | Craig-Hallum bullish on Lifecore, initiates with a Buy |
Latest News for LFCR
CHASKA, Minn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the CPHI Global Conference.
-- Significant New Program Positioned to Become One of Lifecore's Largest Contracts -- -- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product -- -- Program Expected to Contribute to 2028 Commercial Revenues -- CHASKA, Minn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and…
Lifecore Biomedical, Inc. (LFCR) Q2 2026 Earnings Call Transcript
-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -- -- Cost Reduction and Productivity Enhancements Continue to Strengthen Organization -- Conference Call Today at 8:00am ET CHASKA, Minn., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization…
CHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, before the market opens.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFCR.
U.S. House Trading
No House trades found for LFCR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.